Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig I Coleman

Showing results (51-60 of 351) with videos related to

Pageof 36
Sort By:
Pharmacotherapy|April 22, 2005
Probable topical permethrin-induced neck dystoniaCraig I Coleman, Effie L Gillespie, C Michael White
Connecticut Medicine|September 19, 2008
The role of soluble fiber in the management of patients with hypercholesterolemia: a review of the literatureWilliam L Baker, C Michael White, Craig I Coleman
Diabetes Research and Clinical Practice|February 27, 2009
The effect of plant sterols or stanols on lipid parameters in patients with type 2 diabetes: a meta-analysisWilliam L Baker, Erica L Baker, Craig I Coleman
Connecticut Medicine|March 31, 2007
Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary interventionAarti A Patel, C Michael White, Craig I Coleman
Current Medical Research and Opinion|November 15, 2011
Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosisCraig I Coleman, Diana M Sobieraj, Lawrence N Marinucci
Thrombosis and Haemostasis|June 23, 2017
Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolismCraig I Coleman, Thomas J Bunz, Alexander G G Turpie
European Journal of Haematology|January 12, 2020
Rivaroxaban versus apixaban in non-valvular atrial fibrillation patients with end-stage renal disease or receiving dialysisBenjamin Miao, Nitesh Sood, Thomas J Bunz, et al.
Plos One|October 22, 2013
Short-term consequences of angiographically-confirmed coronary stent thrombosisChristine G Kohn, Jeffrey Kluger, Meena Azeem, et al.
Journal of Diabetes and Its Complications|November 22, 2017
Cost-utility of empagliflozin in patients with type 2 diabetes at high cardiovascular riskElaine Nguyen, Craig I Coleman, Suresh Nair, et al.
Current Medical Research and Opinion|April 4, 2008
The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trialsCraig I Coleman, Kurt Reinhart, Jeffrey Kluger, et al.
Pageof 36

Showing results (51-60 of 351) with videos related to

Sort By:
Pageof 36
Pharmacotherapy|April 22, 2005
Probable topical permethrin-induced neck dystoniaCraig I Coleman, Effie L Gillespie, C Michael White
Connecticut Medicine|September 19, 2008
The role of soluble fiber in the management of patients with hypercholesterolemia: a review of the literatureWilliam L Baker, C Michael White, Craig I Coleman
Diabetes Research and Clinical Practice|February 27, 2009
The effect of plant sterols or stanols on lipid parameters in patients with type 2 diabetes: a meta-analysisWilliam L Baker, Erica L Baker, Craig I Coleman
Connecticut Medicine|March 31, 2007
Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary interventionAarti A Patel, C Michael White, Craig I Coleman
Current Medical Research and Opinion|November 15, 2011
Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosisCraig I Coleman, Diana M Sobieraj, Lawrence N Marinucci
Thrombosis and Haemostasis|June 23, 2017
Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolismCraig I Coleman, Thomas J Bunz, Alexander G G Turpie
European Journal of Haematology|January 12, 2020
Rivaroxaban versus apixaban in non-valvular atrial fibrillation patients with end-stage renal disease or receiving dialysisBenjamin Miao, Nitesh Sood, Thomas J Bunz, et al.
Plos One|October 22, 2013
Short-term consequences of angiographically-confirmed coronary stent thrombosisChristine G Kohn, Jeffrey Kluger, Meena Azeem, et al.
Journal of Diabetes and Its Complications|November 22, 2017
Cost-utility of empagliflozin in patients with type 2 diabetes at high cardiovascular riskElaine Nguyen, Craig I Coleman, Suresh Nair, et al.
Current Medical Research and Opinion|April 4, 2008
The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trialsCraig I Coleman, Kurt Reinhart, Jeffrey Kluger, et al.
Pageof 36